Giant coronary artery aneurysm as a feature of coronavirus-related inflammatory syndrome

Kerrie Louise Richardson1, Ankita Jain2, Jennifer Evans3

  • 1Paediatric Cardiology, Noah's Ark Children's Hospital for Wales, Cardiff, UK kerrie.richardson@nhs.net.

BMJ Case Reports
|July 2, 2021
PubMed

Insights

A 5-month-old infant developed a severe Kawasaki-like illness with giant coronary artery aneurysms during the COVID-19 pandemic. This case links atypical Kawasaki disease to pediatric multisystem inflammatory syndrome associated with COVID-19.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Cardiology

Background:

  • The coronavirus pandemic has been associated with various clinical manifestations in children.
  • Kawasaki disease is an acute febrile vasculitis primarily affecting young children.
  • Paediatric multisystem inflammatory syndrome (MIS-C) is a recently recognized condition linked to COVID-19.

Observation:

  • A 5-month-old infant presented with fever, rash, and elevated inflammatory markers, unresponsive to antibiotics.
  • The infant developed giant coronary artery aneurysms despite treatment with intravenous immunoglobulin, steroids, and immunomodulators.
  • Despite an initial negative COVID-19 PCR test, the infant later showed positive COVID-19 antibodies.

Findings:

  • This case demonstrates an atypical presentation resembling Kawasaki disease in an infant.
  • The clinical course was complicated by the development of giant coronary artery aneurysms.
  • The presence of COVID-19 antibodies suggests a link between SARS-CoV-2 infection and the observed illness.

Implications:

  • This case highlights a potential association between atypical Kawasaki-like illness and MIS-C in infants.
  • Early recognition and diagnosis are crucial for managing severe manifestations of MIS-C.
  • Further research is needed to understand the pathophysiology and long-term outcomes of COVID-19-associated vasculitis in children.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
99
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
193
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
121
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
101
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
109
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
558